{"id":708237,"date":[{"year":1985,"month":9,"day":15}],"page":"2","source":"本报","region":"","masthead":"","special_issue":"","column":"","genre":"","count":"209","ytitle":"","mtitle":"治心律失常有新药","ftitle":"","authors":["蒋树芝"],"text":[{"type":"paragraph","text":"本报讯　(记者蒋树芝)国内首创的抗心律失常新药——常咯啉注射液日前在本市通过临床鉴定。此药经八十多例心律失常患者的临床观察，总有效率为百分之八十五。"},{"type":"paragraph","text":"中国科学院上海药物研究所、上海天丰制药厂和上海第十六制药厂在口服常咯啉取得成功的研究和临床经验的基础上，进一步开展临床药效学和药代动力学的研究，又共同研制成功常咯啉注射液。经上海中山、九院等六家医院临床应用，一般给药后十至三十分钟内可使心律失常消失。"}]}